Considering the lack of information on the clinical management of Brazilian patients with HAE, this study aims to identify and characterize patients with HAE-C1-INH that used danazol prophylactic treatment in the Brazilian Public Healthcare System (Sistema Único de Saúde [SUS]). The gene discussed is SERPING1; the disease is hereditary angioedema.